AXID

LOE Approaching

nizatidine

NDAORALCAPSULE
Approved
Apr 1988
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Mechanism of Action

CLINICAL PHARMACOLOGY Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H 2 -receptors, particularly those in the gastric parietal cells. Antisecretory Activity Effects on Acid Secretion Nizatidine significantly inhibited nocturnal gastric acid secretion for up to 12…

Clinical Trials (3)

NCT04050644Phase 4Recruiting

Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery

Started Oct 2018
NCT01775540N/ACompleted

Systane Ultra Versus Maxidex Versus Saline

Started May 2012
NCT01119287Phase 4Completed

Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis

Started Mar 2010
180 enrolled
Allergic Conjunctivitis